MedPath

Effect of biphosphonates on teleangiectasia in irradiated breast cancer patients

Conditions
biphosphonates and telangiectasia in irradiated breast cancer patients.
10006291
10047043
Registration Number
NL-OMON36371
Lead Sponsor
ederlands Kanker Instituut
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

radiotherapie on breast > 6 months ago
will receice biphosphonate
age ><=18 years

Exclusion Criteria

breast radiotherapy < 6 months ago
use of anti-coagulants

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To determine the effects of biphosphonates on radiation induced microvascular<br /><br>damage by comparison of biopsy samples of skin prior to and 4 months after<br /><br>treatment with a biphosphonate. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To determine the effects of biphosphonates on radiation induced<br /><br>micro-lymphovascular damage by comparison of biopsy samples of skin prior to<br /><br>and after treatment with a biphosphonate.</p><br>
© Copyright 2025. All Rights Reserved by MedPath